Palliative Care Certificate Program

We are pleased to announce that the IGCS is launching a series of self-guided, educational certificate programs available to all IGCS Members. The learner can set their own pace to complete the course work, required reading, quizzes, and posttest in easy-to-follow modules.
 
The first certificate program, currently available for members to enroll is the IGCS Palliative Care Certificate Program. Certificate courses are also being developed covering Pre-Invasive Cervical Cancer and International Nursing which will be available soon.
The palliative care curriculum introduces the practicing health care provider to the knowledge and skills necessary to provide palliative interventions for patients suffering associated with women’s cancer.
 
Learning Objectives
After completing the training, the participant will be able to:
  • Describe the scope of knowledge, attitudes, and skills that comprise the core palliative care competencies needed throughout the trajectory of comprehensive cancer care.
  • Incorporate the described treatment recommendations and approaches into clinical practice.
Target Audience
Physicians including gynecologic oncologist, medical oncologist, and radiation oncologist; nurse practitioners, physician assistants, nurses, social workers, and therapists caring for persons with cancer and their families.

If you would like to enroll in the IGCS Palliative Care Certificate program, please sign in with your IGCS Member username and password. You can start learning now! If you need assistance or have questions or feedback about IGCS"s educational offerings please email education@igcs.org.

To optimize your experience, please clear your browsing history and cookies prior to beginning the course. The recommended web browser is Google Chrome.

We’d like to thank our team of volunteers and Mandy Hansen the IGCS staff lead for their efforts in preparing and reviewing the materials and coursework for the IGCS Palliative Care Certificate Program.

Authors
Lee-may Chen, MD 
Raimundo Correa, MD 
Linda R. Duska, MD MPH
Annekathryn Goodman, MD, MS, MA, MPH
Carolyn Lefkowits, MD 
Kristina Lindemann, MD, PhD
Amita Maheshwari, MD 
Michael Pearl, MD 
Shahana Pervin DGO, FCPS
Julia Zarina Ridley, MD, M.Ed, CCFP(PC), FRCPC
Mary (Dicey) Jackson Scroggins, MA
Michael Quinn, AM MGO
Reviewers
Rose Ihuoma Anorlu MD, MPH
Lynette Denny, MD, PhD
Lynn Hallarman, MD
Lois Ramondetta, MD
 
Medical Editor
Jenifer Levin
 
“These certificate courses demonstrate IGCS’s commitment to global health equity. We hope that our members take advantage of these curriculum to enhance their learning and understanding of topics that may have an immediate impact on the health and wellbeing of women in the communities they serve.
 
Designed for practitioners in high- middle- and low-resource settings, these online courses are an excellent way to deliver comprehensive education that our members can complete at their own pace, from any location.”
 
- Dr. Michael Pearl, IGCS Education Committee Member who has been a driving force behind IGCS’s palliative care education.

Patient Perspectives Roundtable

Save these Dates:
Focus on Survivorship/Quality of Life and Patient-Reported Outcomes
Friday, August 6, 2021
9:00 am CDT | 2:00 pm UTC

This 90-minute Virtual Patient Perspectives Roundtable, “Focus on Survivorship/Quality of Life and Patient-Reported Outcomes," is the third in a series of four roundtables sponsored by GSK.

These topics are relevant to patient overall survival, well-being/quality of life, care, and outcomes and cover patient assessments of their cancer experience, all in and beyond the backdrop of COVID-19 and of global discussions of health equity. Participating in this active exchange of information will enhance understanding of these important topics and empower attendees.

Stay tuned for Registration information & the announcement of the Moderator & Panelists.
 
Global Health Equity: Conversation to Implementation
Friday, October 15, 2021
9:00 am CDT | 2:00 pm UTC

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.

Previous Roundtables

Spotlight on Endometrial Cancer: Breakthroughs & Concerns
Recorded on May 14, 2021
Sponsored by GSK

Navigating Telehealth/Telemedicine & Embracing Shared Decision Making
Recorded November 21, 2020
Sponsored by GSK

Patient Advocacy & Support in the Backdrop of COVID-19
Recorded June 30, 2020

Gynecologic Cancer Patient Care & Clinical Trials in the Midst of COVID-19
Recorded May 23, 2020
Sponsored by GOG Foundation

2021 Award Recipients

In 2016, IGCS expanded its awards program to recognize the good work being done to advance the field of gynecologic oncology worldwide. Award recipients are recognized at the IGCS Annual Global Meeting.

Lifetime Achievement Award

Recognizes individual(s) who have performed an outstanding service and accomplishment spanning their career in gynecologic oncology. The goal is to recognize a life of excellence and service to gynecologic oncology. Formerly referred to as the Award for Excellence in Gynecologic Oncology.

Beth Y. Karlan, MD
USA
Read more

Michael Quinn, AM, MGO
Australia
Read more

Award for Outstanding Achievement in Gynecologic Oncology Surgery

Recognizes gynecologic oncologists who have had a sustained career in academic surgery and have made seminal contributions in clinical surgery or surgical education that established new benchmarks or paradigms.

Pierluigi Benedetti Panici, MD 
Italy
Read more

Global Humanitarian Award

Recognizes outstanding individuals, organizations or programs who work to improve access to quality gynecologic oncology training and services in low- and middle-income countries or in areas of need within more developed nations.

Tri Dinh, MD
USA
Read more

Distinguished Advocacy Award

Recognizes advocates and/or advocacy organizations that provide active, dedicated service to patients/survivors, families, and caregivers—on a local, regional, or international level—and persistently engage in the fight against gynecologic and other cancers.

Elisabeth Baugh and
Ovarian Cancer Canada  
Canada
Read more

Murat Gultekin, MD       
Turkey
Read more

Abhishek Shankar, MD
India
Read more

Excellence in Teaching Award

Recognizes individuals deeply committed to the profession whose work and accomplishments set a standard of excellence. This award recognizes the importance of teaching as an integral part of women's cancer care and the lasting impact of educators to shape and inspire future generations of clinicians and researchers.

Nadeem Abu-Rustum, MD
USA
Read more

Hextan YS Ngan, MD
Hong Kong
Read more

Andreas Obermair, MD, CGO
Australia
Read more

Award for Community Advancement in Resource-Limited Settings

Acknowledges those improving their own communities with dedication to providing or facilitating advanced medical education and training in resource-limited settings to improve screening, prevention, and treatment of women affected by gynecologic cancer.

Asima Mukhopadhyay, MBBS, DGO, MD, MRCOG, CCT (Gyn Oncology), PhD, MSc
India/UK
Read more

René Pareja, MD
Colombia
Read more

Introducing IGCS COVID Safety Officer

Introducing IGCS COVID Safety Officer, Dr. Alessandro Cartelli

COVID-19 Health & Safety Guidelines and Requirements

  • Rapid testing is required for all delegates. Testing will be offered at the meeting venue on Sunday, August 29 and will remain available throughout the conference.
  • All meeting delegates must be tested by the IGCS COVID team and show a negative test result at the time of registration in order to enter the venue.

COVID-19 Health & Safety Guidelines and Requirements

  • Rapid testing is required for all delegates. Testing will be offered at the meeting venue on Sunday, August 29 and will remain available throughout the conference.
  • All meeting delegates must be tested by the IGCS COVID team and show a negative test result at the time of registration in order to enter the venue.
  • Face masks must be worn by all delegates at the congress while indoors as an extra safety precaution.
  • To accommodate social distancing at the Auditorium, a maximum of 500 in-person tickets will be sold. Seating within the halls has been spaced to adhere to social distance guidelines, currently 1m.
  • If a delegate tests positive for COVID-19, a molecular PCR test will be issued. If found positive, the delegate will not be allowed to enter the auditorium and will be advised on safe transportation from the auditorium to their hotel.

COVID-19 Health & Safety FAQ

Q: What Coronavirus-related safety precautions are being taken for meeting delegates in Rome?
A: IGCS is committed to the health and safety of our delegates, staff, and everyone who works at the meeting venue. We have been working closely with officials at the Auditorium, the local conference organizer, and receiving updates from the Italian government and we have implemented the following guidelines and procedures regarding COVID-19 safety.

Q: How many people will be able to attend in-person?
A: To accommodate social distancing at the Auditorium, a maximum of 500 in-person tickets will be sold.

Q: What is the COVID Safety Officer’s responsibility?
A: IGCS has appointed Dr. Alessandro Cartelli as COVID Safety Officer. He will be responsible for ensuring that guidelines are followed, and proper steps are taken in the event of a positive COVID case. For questions, please email Dr. Cartelli.

Q: What testing will be required to be admitted to the meeting venue?
A: Our onsite team will be conducting rapid testing with the STANDARD Q COVID-19 Ag Test by SD BIOSENSOR.  It is a rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in human nasopharynx, approved by the Italian and European FDA and is valid for the screening of this population. The specimen is collected though a nasopharyngeal swab. Test results will be available after 15 minutes and those who test negative will proceed to registration to collect their Congress information.

Q: When will I need to be tested?
A: All meeting delegates must be tested by the IGCS COVID team and show a negative test at the time of registration. Testing will be offered at the meeting venue on Sunday, August 29, 2021 and will remain available throughout the conference.

Q: Is IGCS testing required if I recently completed testing somewhere else?
A: Yes, the test done by IGCS is required. COVID tests that have been done elsewhere and Green passes issued in the EU will not be accepted to grant access to the Congress. All delegates must have a negative test performed by the IGCS team at the venue. IGCS is covering the cost of the required COVID test for entry.

Q: What if I am not in Rome on August 29th to get tested by the IGCS team?
A: Testing stations will be available throughout the duration of the meeting.

Q: What happens if I test positive for COVID-19?
A: If a delegate tests positive for COVID-19, a molecular PCR test will be issued. If found positive, the delegate will not be allowed to enter the auditorium and will be advised on safe transportation from the auditorium to their hotel. The IGCS COVID team will provide them with information and assistance on local medical care and further testing facilities as needed. Note that any required PCR testing and transportation away from the venue will be at the expense of the delegate. The delegate will receive a registration conversion from an in-person pass to a virtual pass and will receive the appropriate refund in price in adherence to the IGCS registration conversion and cancellation policy.

Q: What are the current safety measures in place at The Auditorium?
A: The Auditorium has provided detailed safety measures that will be shared with delegates attending in-person in advance of the meeting. At this time, guidelines include but are not limited to:

  • Temperature checks upon entering the Auditorium.
  • All those entering the Auditorium will be required to wear an FFP2 face mask at all times while in the Auditorium.   
  • Seating within the halls has been spaced to adhere to social distance guidelines, currently 1m. A maximum of 500 delegates will be allowed.
  • Notices stating safety regulations to be followed, aimed principally at the audience, will be displayed at various points inside the Auditorium.

Q: Is there any information that I need to be aware of regarding COVID-19 and travel?
A: Click here for important information from the Italian Ministry of Health regarding travel and COVID-19. This includes specific information about the classification of territories, travel restrictions, rules, and requirements for travelling to and from abroad.

Dr. Chege Completes IGCS Curriculum

Congratulations to Dr. Henry Chege from Moi University in Kenya for completing the IGCS Gynecologic Oncology Global Curriculum & Mentorship Program!

Dr. Henry Chege
Moi University, Kenya

“I thank all of you for the support you accorded me during the IGCS fellowship training. To the international mentors Prof. Barry and Prof. Al Covens, thank you for taking time to travel all the way to Kenya to supervise the training. I will always be indebted to these great mentors.”

This fellowship program is the first fellowship in any medical field approved by Moi University. The IGCS Global Curriculum was established in 2017 under the leadership of then-President, Michael Quinn. It is a comprehensive two-year education and training program designed for regions around the world that do not currently have formal training in gynecologic oncology. Click here to learn more about the program.

Congratulations to Dr. Chege on achieving this important milestone. Many thanks to the local and international mentors for their support and guidance.

Local Mentors

Dr. Benjamin Elly
Moi University
Kenya

Dr. Peter Itsura
Moi University
Kenya

Dr. Omenge Orango
Moi University
Kenya

International Mentors

Dr. Barry Rosen
Beaumont Gynecologic Oncology
USA

Dr. Al Covens
Sunnybrook Health Sciences Centre
The University of Toronto
Canada

Dr. Barry Rosen, International Mentor congratulates Dr. Chege: "You made a very impressive, total commitment Henry, giving up your clinic practice, giving up money you would have made to do this training. And you had delays (out of your control) along the way which must have been very frustrating. It is a very big accomplishment. You are now internationally recognized for your expertise. Kenyan women will benefit so much from your expertise and your future training of other doctors. I wish I could be in Kenya to congratulate you in person.”

Volunteer to Support IGCS Mentorship & Training Programs

We are always looking for volunteer leaders of all disciplines to support our mentorship and training programs. If you are interested in becoming a mentor or contributing to our virtual tumor boards, please contact Susan Ralph at susan.ralph@igcs.org.

IJGC Impact Factor Rises

IGCS Members and Friends,

We are extremely proud to announce that the latest Impact Factor for the International Journal of Gynecological Cancer is 3.44. This represents a 64% increase over 2019. Additional journal metrics can be viewed here.

Dr. Pedro Ramirez became the IJGC Editor in Chief in January 2019. We’d like to congratulate him on this achievement and applaud the efforts of the Associate Editors, Editorial Board, our Publisher BMJ and the journal's Managing Editor, Lindsey Struckmeyer.

IGCS Council Member Dr. Rainer Kimmig commented, "Its great to see the success of our journal which represents work and research being conducted in various regions of the world highlighting key issues critical to patients not only in developed countries but also in low-resource countries."

Dr. Pedro Ramirez shares his sentiments: “Our team wishes to thank all who have supported and continue to support our journal and for submitting your research work. We are grateful for the support of the International Gynecologic Cancer Society and the European Society of Gynecological Oncology, as well as our Managing Editors, and our Publisher BMJ. I would also like to personally express my gratitude to our outstanding team of Associate Editors and our Editorial Board.”

IJGC is the scientific publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach and includes original research (clinical trials and translational or basic research), reviews, and opinion pieces.

Submit your work to the International Journal of Gynecological Cancer.

Make sure you are taking advantage of all the benefits of being a subscriber to IJGC including weekly podcasts with leading experts discussing the latest research in their respective and monthly Zoom journal club discussions where members of our Editorial Board join the authors of IJGC lead articles to discuss and debate their research and other relevant topics in a collegial, informal setting.

Again, congratulations to Pedro and the entire IJGC team!

Robert Coleman, MD
IGCS President

Mary Eiken, MS
IGCS CEO

Follow IJGC on Facebook and Twitter to learn about the latest articles, podcasts, journal club discussions and more. Follow the IJGC Fellows on Twitter for additional content.

IJGC Journal Club

IJGC Journal Club, in collaboration with IGCS and ESGO
Tuesday, August 10, 2021

8:00am CDT (Chicago, USA) | 3:00pm CEST (Rome, Italy) 

August Lead Article for Discussion:
Minimally invasive hysterectomy for stage IA cervical carcinoma: a survival analysis of the National Cancer Database by Dimitrios Nasioudis 

The discussion will be recorded and made available to the public.  Participants with cameras turned on may appear in the video recording or their name may appear on the screen. By joining the zoom videoconference, participants are agreeing that they may appear in the recording. Participants can turn off their camera and change their username once they enter the zoom meeting room. To change your name on Zoom, Click the "Participants" button at the bottom of the Zoom window. Next, hover over your name in the "Participants" list and click on "Rename." Enter your new screen name and click "OK."

Previously Recorded Journal Club Discussions

IGCS 2021 Registration Options

In this video message, Scientific Program Committee Co-Chair, Dr. Matthew Powell, describes the multiple ways you can register for IGCS 2021.

Whether you choose to attend the Annual Meeting in Rome, virtually, or by gathering locally, IGCS 2021 is a great opportunity to expand your professional network and collaborate with colleagues from around the world.

Register for IGCS 2021

Group Registration 

 

Did you miss our last video message?
View Dr. Coleman’s video message regarding the Presidential Plenary at IGCS 2021.

Preliminary Program Now Available

The 2021 IGCS Annual Global Meeting is being held in Rome at the Auditorium Parco della Musica with portions of the program being held in a digital environment so that delegates unable to travel may participate remotely.

Planning for Rome? Health & Safety Information

Safety is of course our utmost priority and the IGCS team is working very closely with a local professional conference organizer, the venue, and the Italian government as rules and regulations are released for safe ways to gather with an abundancy of caution.

  • To accommodate social distancing at the Auditorium, a maximum of 650 in-person tickets will be sold. There is no limit on virtual registration.
  • IGCS has appointed COVID Safety Officers responsible for ensuring that guidelines are followed, and proper steps are taken in the event of a positive COVID case. The names and contact information of the COVID Safety Officers will be made prominently available for all delegates to contact with any questions or for any reason before and during the meeting.
  • 48 hours in advance of the IGCS meeting, a negative COVID test result is required for delegates to be admitted to the meeting venue. IGCS will offer rapid testing at the meeting venue August 28th & 29th and will provide a list of alternate testing locations in Rome.
  • The Auditorium has provided detailed safety measures that will be shared with delegates attending in-person in advance of the meeting.
Learn More About Health & Safety Information

 

We continue to be most appreciative to the Società Italiana di Oncologia Ginecologica (SIOG) and the Società Italiana di Ginecologia e Ostetrica (SIGO) for their continued support and partnership in planning Rome 2021.

Read more in the welcome letter from the 2021 Scientific Program Committee Chairs. Please check back regularly for updates about the IGCS 2021 Annual Global Meeting. Join us in thinking bold!

2021 Scientific Program Committee Chairs

Ana Oaknin, MD, PhD (Spain)

Matthew Powell, MD (USA)

2021 Scientific Program Committee Roster

Co-Chair: Ana Oaknin (Spain)

Co-Chair: Matthew Powell (USA)

Angeles Alvarez Secord (USA)

Susana Banerjee (UK)

Paul Cohen (Australia)

Christina Fotopoulou (UK)

Gonzalo Giornelli (Argentina)

Salvatore Gueli Alletti (Italy)

Gustavo Guitmann (Brazil)

Saketh Guntupalli (USA)

Anuja Jhingran (USA)

Hee-Seung Kim  (Republic of Korea)

Ann Klopp (USA)

Satoru Kyo (Japan)

Mario Leitao (USA)

Domenica Lorruso (Italy)

Sven Mahner (Germany)

Vicky Makker (USA)

Xavier Matias-Guiu (Spain)

Jyoty Mayadev (USA)

Bradley Monk (USA)

Amanda Nickles Fader (USA)

Aikou Okamoto (Japan)

David O’Malley (USA)

Francesco Plotti (Italy)

Leslie Randall (USA)

Isabelle Ray-Coquard (France)

BJ Rimel (USA)

Clare Scott (Australia)

A.G.J. van der Zee (The Netherlands)

Key Dates

General Abstract Submission Deadline: May 12th
Early Registration Deadline: July 13th
Late Breaking Abstract Submission: June 8 – June 29th

Preliminary Program Details

  • 3.5 days of programming
  • Delegates may attend in person or virtually
  • Master Sessions on ovarian, cervix, uterine, and vulvar cancers are back by popular demand
  • Surgical education track
  • Oral abstract presentations
  • Continuing medical education credits for live and on-demand sessions
  • The featured poster sessions and virtual abstract poster hall will be just as robust as the 2020 meeting with the poster hall featuring audio recordings from the authors
Learn More About the Program

 

Optimizing Engagement with the Latest Virtual Meeting Technology and Hub & Spoke Model

Expanding on the success of the fully digital 2020 IGCS Annual Global Meeting, IGCS 2021 will utilize the latest virtual meeting technology to broadcast engaging sessions and provide delegates access to hundreds of virtual abstract posters and audio recordings.

Engagement is major priority for IGCS 2021, and we have found a unique way to disseminate our education globally without sacrificing personal interaction for those who cannot be in Rome. With the virtual platform we will be using a “hub and spoke” approach that will allow us to broadcast from Rome as the hub, to many locations where gynecologic oncology professionals may gather all over the globe – thus creating the spokes.

We are encouraging regional gatherings of delegates when conducive and identifying local key opinion leaders in each of these regions to interact with the speakers and moderators in Rome to provide a similar effect and impact as to being there in person.

Learn More About the Hub & Spoke Meeting Model

 

Registration Options

Delegates have the option to attend in person or participate virtually. Those who attend in person will have full access to the virtual platform. Group registration available for all options. Visit igcs2021.com/registration for more information.

Learn More About Registration Options

 

IGCS 2021 Presidential Plenary

In this video message, Dr. Coleman reveals that this year’s Presidential Plenary will focus on current clinical trials and international efforts to work cooperatively, ensuring research dedicated to women’s cancers continues to advance globally.

The Presidential Plenary will be held on Tuesday, August 31 at 2:30pm Central European Time.

During the plenary, invited guests from the GOG – (Gynecologic Oncology Group Partners) and ENGOT – (the European Network for Gynaecological Oncological Trial Group) will share the latest information and relevant clinical trials in progress. These groups operate through global partnerships and emulate so much of how the IGCS operates day in and day out… through the success of partnerships and international collaboration.